论文部分内容阅读
目的:探讨胺碘酮治疗心律失常的临床效果。方法:选择2015年2月至2016年2月重庆市第一人民医院接收的150例心律失常患者,对照组给予常规心律平治疗,观察组在对照组的基础上增加胺碘酮治疗。结果:观察组的治疗总有效率优于对照组,差异具有统计学意义(P<0.05);观察组的治疗后0.5 h、治疗后12 h、治疗后24 h的心率均显著低于对照组,差异具有统计学意义(P<0.05);观察组的不良反应率低于对照组,差异具有统计学意义(P<0.05)。结论:胺碘酮治疗心律失常的临床疗效较好,不良反应相对较少,安全性较高。
Objective: To investigate the clinical effect of amiodarone on arrhythmia. Methods: A total of 150 patients with arrhythmia received from Chongqing First People’s Hospital from February 2015 to February 2016 were selected. Patients in the control group were treated with conventional cardioversion. Amiodarone was added to the observation group on the basis of the control group. Results: The total effective rate of the observation group was better than that of the control group (P <0.05); the heart rate of the observation group at 0.5 h, 12 h after treatment and 24 h after the treatment was significantly lower than that of the control group , The difference was statistically significant (P <0.05); adverse reactions in the observation group was lower than the control group, the difference was statistically significant (P <0.05). Conclusion: The clinical efficacy of amiodarone in the treatment of arrhythmia is better, with fewer adverse reactions and higher safety.